Page 45 - AN-3-4

Advanced Neurology Anticoagulants as neuroprotective therapeutics

39. Fagan A, Xiong CX Jasielec MS, et al. Longitudinal change disease. Nature. 2018;560(7717):185-191.
in CSF biomarkers in autosomal-dominant Alzheimer’s doi: 10.1038/s41586-018-0368-8
disease. Sci Transl Med. 2014;6(226):226ra30.
51. Zamolodchikov D, Chen Z.L, Conti BA, Renne T, Strickland
doi: 10.1126/scitranslmed.3007901
S. Activation of the factor XII-driven contact system in
40. Preische O, Schultz SA Apel A, et al. Serum neurofilament Alzheimer’s disease patient and mouse model plasma. Proc
dynamics predicts neurodegeneration and clinical Natl Acad Sci USA. 2015;112(13):4068-4073.
progression in presymptomatic Alzheimer’s disease. Nat
Med. 2019;25(2):277-283. doi: 10.1073/pnas.1423764112
52. Zamolodchikov D, Renne T, Strickland S. The Alzheimer’s
doi: 10.1038/s41591-018-0304-3
disease peptide β-amyloid promotes thrombin generation
41. Broce IJ, Tan CH, Fan CC, et al. Dissecting the genetic through activation of coagulation factor XII. J Thromb
relationship between cardiovascular risk factors and Haemost. 2016;14(5):995-1007.
Alzheimer’s disease. Acta Neuropath. 2019;137:209-226.
53. Cortes-Canteli M, Paul J, Norris EH, et al. Fibrinogen and
doi: 10.1007/s00401-018-1928-6 β-amyloid association alters thrombosis and fibrinolysis:
42. Rother C, Uhlmann RE, Müller SA, et al. Experimental A possible contributing factor to Alzheimer’s disease.
evidence for temporal uncoupling of brain Aβ deposition Neuron. 2010;66(5):695-709.
and neurodegenerative sequelae. Nat Com. 2022;13(1):7333. doi: 10.1016/j.neuron.2010.05.014
doi: 10.1038/s41467-022-34538-5 54. Donohue M, Sperling RA, Petersen R, Sun CK, Weiner MW,
43. Gilbert MA, Fatima N, Jenkins J, et al. CryoET of β-amyloid Aisen PS. Association between elevated brain amyloid and
and tau within postmortem Alzheimer’s disease brain. subsequent cognitive decline among cognitively normal
Nature. 2024;631(8022):913-919. persons. JAMA. 2017;317(22):2305-2316.
doi: 10.1038/s41586-024-07680-x doi: 10.1001/jama.2017.6669
44. Yubolphan R, Pratchayasakul W, Koonrungsesomboon N, 55. Ghosh U, Yau WM, Collinge J, Tycko R. Structural
Chattipakorn N, Chattipakorn SC. Potential links between differences in amyloid-β fibrils from brains of nondemented
platelets and amyloid-β in the pathogenesis of Alzheimer’s elderly individuals and Alzheimer’s disease patients. Proc
disease: Evidence from in vitro, in vivo, and clinical studies. Natl Acad Sci USA. 2021;118(45):e2111863118.
Exp Neurol. 2024;374:114683. doi: 10.1073/pnas.2111863118
doi: 10.1016/j.expneurol.2024.114683 56. Jensen AM, Kitago Y, Fazeli E, et al. Dimerization of the
45. Habashi M, Vutla S, Tripathi K, et al. Early diagnosis Alzheimer’s disease pathogenic receptor SORLA regulates
and treatment of Alzheimer’s disease by targeting its association with retromer. Proc Natl Acad Sci USA.
toxic soluble Aβ oligomers. Proc Natl Acad Sci USA. 2023;120(4):e2212180120.
2022;119(49):e2210766119. doi: 10.1073/pnas.2212180120
doi: 10.1073/pnas.2210766119 57. Sun YY, Wang Z, Huang HC. Roles of ApoE4 on
46. Treder MS, Chares I, Michelmann S, et al. The hippocampus the pathogenesis in Alzheimer’s disease and the
as the switchboard between perception and memory. Proc potential therapeutic approaches. Cell Mol Neurobiol.
Natl Acad Sci USA. 2021;118(50):e2114171118. 2023;43(7):3115-3136.
doi: 10.1073/pnas.2114171118 doi: 10.1007/s10571-023-01365-1

47. Yuan P, Zhang, M, Tong L, et al. PLD3 affects axonal 58. Blanchard JW, Akay LA, Davila-Velderrain J, et al. APOE4
spheroids and network defects in Alzheimer’s disease. impairs myelination via cholesterol dysregulation in
Nature. 2022;612(7939):328-337. oligodendrocytes. Nature. 2022;611(7937):769-779.
doi: 10.1038/s41586-022-05491-6 doi: 10.1038/s41586-022-05439-w
48. Aoyagi A Condello C, Stöhr J, et al. Aß and tau prion-like 59. Xiong M, Jiang H, Serrano JR, et al. APOE immunotherapy
activities decline with longevity in the Alzheimer’s disease reduces cerebral amyloid angiopathy and amyloid plaques
human brain. Sci Transl Med. 2019;11(490):eaat8462. while improving cerebrovascular function. Sci Transl Med.
2021;13:eabd7522.
49. Scheffer S, Hermkens AM, Van der Weerd L, De Vries HE,
Daemen MJ. Vascular hypothesis of Alzheimer’s disease. doi: 10.1126/scitranslmed.abd7522
Arterioscler Thromb Vasc Biol. 2021;41:1265-1283. 60. Wang H, Kulas J.A, Wang C, Holtzman DM, Ferris HA,
50. Da Mesquita S, Louveau A, Vaccari A, et al. Functional Hansen SB. Regulation of beta-amyloid production in
aspects of meningeal lymphatics in ageing and Alzheimer’s neurons by astrocyte-derived cholesterol. Proc Natl Acad Sci

Volume 3 Issue 4 (2024) 27 doi: 10.36922/an.3799